| Followers | 1397 |
| Posts | 59304 |
| Boards Moderated | 6 |
| Alias Born | 11/08/2005 |
Wednesday, September 06, 2006 4:59:50 PM
Pretty good FernBlade, How's life treatin' ya? That deer is really cute, cuter than the ones in my parent's backyard. Pops tells me that he had to put a fence around his garden because they kept chewing on everything. LOL
Looks like no solid green here for a few days on and off but very confident we'll see a huge green one very soon.
Been a lonnnnnnnnnnnnnnnng day for me. So many things going on. gave the deadbeat tenant the boot but the deadbeat left their trash and cat in the garage. Gosh.
Well anyway I'm wondering what I'll have for dinner tonight. Personally, anything that smells like nano-moneyyyyyyyyyy I wouldn't mind cookin'. Anyone know how many calories nanomicelles have per bottle?
Looks like no solid green here for a few days on and off but very confident we'll see a huge green one very soon.
Been a lonnnnnnnnnnnnnnnng day for me. So many things going on. gave the deadbeat tenant the boot but the deadbeat left their trash and cat in the garage. Gosh.
Well anyway I'm wondering what I'll have for dinner tonight. Personally, anything that smells like nano-moneyyyyyyyyyy I wouldn't mind cookin'. Anyone know how many calories nanomicelles have per bottle?
investorshub.advfn.com/boards/board.asp?board_id=8793[tag]
****** Trade with T/A * F ******
[/tag] #board7516 10BaggasFactory
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
